Recruiting Migraine Studies in Washington D.C.
About Migraine Clinical Trials in Washington D.C.
Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.
There are currently 4 migraine clinical trials recruiting participants in Washington D.C., DC. These studies are seeking a combined 981 participants. Research is being sponsored by Pfizer, H. Lundbeck A/S, American University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Migraine Clinical Trials in Washington D.C. — FAQ
Are there migraine clinical trials in Washington D.C.?
Yes, there are 4 migraine clinical trials currently recruiting in Washington D.C., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.C.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.C. research site will contact you about next steps.
Are clinical trials in Washington D.C. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.C. studies also compensate for your time and travel.
What migraine treatments are being tested?
The 4 active trials in Washington D.C. are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.
Data updated November 15, 2026 from ClinicalTrials.gov